PatientsVille.com Logo

PatientsVille

Torvast Side Effects

Common Torvast Side Effects


The most commonly reported Torvast side effects (click to view or check a box to report):

Rhabdomyolysis (9)
Myalgia (8)
Rash (6)
Gamma-glutamyltransferase Increased (6)
Pruritus (5)
Hepatitis Cholestatic (5)
Blood Creatine Phosphokinase Increased (5)
Hypertransaminasaemia (4)
Asthenia (4)
Vomiting (4)
Hepatitis Acute (3)
Abdominal Pain Upper (3)
Blood Alkaline Phosphatase Increased (3)
Jaundice (3)
Weight Decreased (3)
Liver Disorder (3)
Respiratory Failure (3)
Myopathy (3)
Necrosis (2)
Oliguria (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Torvast Side Effects Reported to FDA

The following Torvast reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Torvast on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Myalgia
This is a report of a 37-year-old male patient (weight: NA) from IT, suffering from the following symptoms/conditions: infarction, who was treated with Torvast (dosage: 80 Mg, 1x/day, start time: Sep 16, 2012), combined with:
  • Cardioaspirin (100 Mg, Unk)
  • Efient (10 Mg, Unk)
  • Triatec (1.25 Mg, Unk)
  • Cardicor (2.5 Mg, Unk)
  • Eskim (2000 Mg, Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Blood Creatine Phosphokinase Increased
  • Blood Lactate Dehydrogenase Increased
  • Myalgia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in male patients, resulting in blood creatine phosphokinase increased side effect.

Pruritus, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
This report suggests a potential Torvast Pruritus, Blood Creatine Phosphokinase Increased, Rhabdomyolysis side effect(s) that can have serious consequences. A 39-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: dyslipidaemia,diabetes mellitus and used Torvast (dosage: Unk) starting NS. Soon after starting Torvast the patient began experiencing various side effects, including:
  • Pruritus
  • Blood Creatine Phosphokinase Increased
  • Rhabdomyolysis
Drugs used concurrently:
  • Metformin (500 Mg, 3x/day)
The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pruritus, may still occur.

Aggression, Agitation, Insomnia
This Aggression, Agitation, Insomnia problem was reported by a pharmacist from IT. A 91-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: hypercholesterolaemia,hypothyroidism. On Aug 07, 2013 this consumer started treatment with Torvast (dosage: 10 Mg, Daily). The following drugs were being taken at the same time:
  • Eutirox (50 Ug, Daily)
When commencing Torvast, the patient experienced the following unwanted symptoms/side effects:
  • Aggression
  • Agitation
  • Insomnia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as aggression, may become evident only after a product is in use by the general population.

Hepatic Enzyme Increased, Hepatic Failure, Intracardiac Thrombus
This is a report of a 86-year-old female patient (weight: NA) from IT. The patient developed the following symptoms/conditions: NA and was treated with Torvast (dosage: 40 Mg, Daily) starting Oct 06, 2013. Concurrently used drugs:
  • Metformin Hcl (3000 Mg, Daily)
  • Plavix (75 Mg, Daily)
  • Levopraid (37.5 Mg, Unk)
  • Fosfomycina Ratiopharm (1 Df, Unk)
Soon after that, the consumer experienced the following side effects:
  • Hepatic Enzyme Increased
  • Hepatic Failure
  • Intracardiac Thrombus
The patient was hospitalized. This opens a possibility that Torvast treatment could cause the above reactions, including hepatic enzyme increased, and some female subjects may be more susceptible.


Rhabdomyolysis, Colitis, Plantar Fasciitis, Tendonitis
A 72-year-old male patient (weight: NA) from IT with the following symptoms/conditions: coronary artery disease started Torvast treatment (dosage: 10 Mg, 1x/day) on Jan 01, 2004. Soon after starting Torvast treatment, the subject experienced various side effects, including:
  • Rhabdomyolysis
  • Colitis
  • Plantar Fasciitis
  • Tendonitis
Concurrently used drugs:
  • Acetylsalicylic Acid (100 Mg, Unk)
  • Pantoprazole (1 Df, Unk)
  • Glibomet (3 Df, Unk)
  • Lantus (25 Iu, Unk)
  • Pritorplus (1 Df, Unk)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Torvast.

Diabetes Mellitus
A 85-year-old male patient from IT (weight: NA) experienced symptoms, such as: hyperlipidaemia,hypertension and was treated with Torvast(dosage: 10 Mg, Daily). The treatment was initiated on Apr 17, 2012. After that a consumer reported the following side effect(s):
  • Diabetes Mellitus
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Torvast efficacy:
  • Altiazem (180 Mg, Daily)
  • Soldesam (4 Mg, Unk)
  • Keppra (1 Df, Unk)
  • Monocinque (20 Mg, Unk)
  • Clexane (1 Df, Unk)
  • Zestril (20 Mg, Unk)
The patient was hospitalized.

Retinal Haemorrhage
In this report, Torvast was administered for the following condition: hypercholesterolaemia.A 50-year-old male consumer from IT (weight: NA) started Torvast treatment (dosage: 10 Mg, Daily) on Nov 03, 2012.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Retinal Haemorrhage
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Torvast treatment could be related to the listed above side effect(s).

Loss Of Consciousness
This is a report of the following Torvast side effect(s):
  • Loss Of Consciousness
A 93-year-old female patient from IT (weight: NA) presented with the following condition: NA and received a treatment with Torvast (dosage: 1 Df, Daily) starting: Apr 15, 2013.The following concurrently used drugs could have generated interactions:
  • Cordarone (1 Df, Daily)
  • Coumadin (10 Milligram(s);daily (2 Dose Form Daily))
  • Micardis (1 Df, 1x/day)
This report suggests that a Torvast treatment could be associated with the listed above side effect(s).

Asthenia, Muscle Atrophy, Myalgia
This Torvast report was submitted by a 67-year-old female consumer from IT (weight: NA). The patient was diagnosed with: prophylaxis and Torvast was administered (dosage: 40 Mg, 1x/day) starting: Apr 13, 2013. The consumer developed a set of symptoms:
  • Asthenia
  • Muscle Atrophy
  • Myalgia
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Torvast treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pancreatitis, Presyncope
This is a report of a possible correlation between Torvast use and the following symptoms/side effect(s):
  • Pancreatitis
  • Presyncope
which could contribute to an assessment of Torvast risk profile.A 73-year-old male consumer from IT (weight: NA) was suffering from hyperlipidaemia and was treated with Torvast (dosage: 10 Mg, Daily) starting Jan 08, 2013.Other concurrent medications:
  • Pantoprazole (20 Mg, Unk)
  • Allopurinol (300 Mg, Unk)
  • Ventolin (Unk)
  • Gaviscon (Unk)
The patient was hospitalized.

Dysuria, Erythema, Pruritus
A 46-year-old male patient from IT (weight: NA) presented with the following symptoms: NA and after a treatment with Torvast (dosage: 80 Mg, Daily) experienced the following side effect(s):
  • Dysuria
  • Erythema
  • Pruritus
The treatment was started on Mar 01, 2013. Torvast was used in combination with the following drugs:
  • Effient (10 Mg)
  • Congescor (1.25 Mg)
  • Pantorc (20 Mg)
This report could alert potential Torvast consumers.

Myalgia, Abdominal Pain Upper, Paraesthesia
In this report, a 50-year-old male patient from IT (weight: NA) was affected by a possible Torvast side effect.The patient was diagnosed with hypercholesterolaemia. After a treatment with Torvast (dosage: 80 Mg, 1x/day, start date: Mar 25, 2013), the patient experienced the following side effect(s):
  • Myalgia
  • Abdominal Pain Upper
  • Paraesthesia
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Torvast treatment.

Anaemia, Myalgia, Rhabdomyolysis, Renal Failure
This is a report of a 84-year-old patient from IT (weight: NA), who used Torvast (dosage: 40 Mg, Daily) for a treatment of arteriosclerosis. After starting a treatment on May 15, 2013, the patient experienced the following side effect(s):
  • Anaemia
  • Myalgia
  • Rhabdomyolysis
  • Renal Failure
The following drugs could possibly have interacted with the Torvast treatment
  • Norvasc
  • Antra
  • Cardioaspirin
  • Cefamezin ^pharmacia-upjohn^
  • Lortaan
  • Clexane
  • Zyloric
The patient was hospitalized.Taken together, these observations suggest that a Torvast treatment could be related to side effect(s), such as Anaemia, Myalgia, Rhabdomyolysis, Renal Failure.

Hypersensitivity
This hypersensitivity side effect was reported by a physician from IT. A 75-year-old male patient (weight:NA) experienced the following symptoms/conditions: coronary artery disease. The patient was prescribed Torvast (dosage: 80 Mg, 1x/day), which was started on Apr 28, 2013. Concurrently used drugs:
  • Ranexa (750 Mg, 1x/day)
  • Plavix (Unk)
  • Irbesartan (Unk)
  • Pantoprazole (Unk)
When starting to take Torvast the consumer reported the following symptoms:
  • Hypersensitivity
These side effects may potentially be related to Torvast.

Gamma-glutamyltransferase Increased, Hypertransaminasaemia
This is a Torvast side effect report of a 69-year-old patient (weight:NA) from IT, suffering from the following symptoms/conditions: NA, who was treated with Torvast (dosage:20 Mg Daily, start time: Jan 21, 2013), combined with: NA., and developed a serious reaction and a gamma-glutamyltransferase increased side effect. The patient presented with:
  • Gamma-glutamyltransferase Increased
  • Hypertransaminasaemia
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Torvast treatment in patients suffering from NA, resulting in gamma-glutamyltransferase increased.

Renal Failure, Rhabdomyolysis, Thrombocytopenia, Epistaxis, Hypotension, Hyponatraemia, White Blood Cell Count Decreased, Red Blood Cell Count Decreased
This report suggests a potential Torvast renal failure side effect(s) that can have serious consequences. A 48-year-old male patient from IT (weight:NA) was diagnosed with the following health condition(s): arteriosclerosis and used Torvast (dosage: 40 Mg, Daily) starting Jan 01, 2010. Soon after starting Torvast the patient began experiencing various side effects, including:
  • Renal Failure
  • Rhabdomyolysis
  • Thrombocytopenia
  • Epistaxis
  • Hypotension
  • Hyponatraemia
  • White Blood Cell Count Decreased
  • Red Blood Cell Count Decreased
Drugs used concurrently:NA. The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as renal failure, may still occur.

Hypercreatinaemia, Blood Creatine Phosphokinase Increased
This hypercreatinaemia problem was reported by a physician from IT. A 77-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): hypercholesterolaemia.On May 10, 2010 a consumer started treatment with Torvast (dosage: 10 Mg, Daily). The following drugs/medications were being taken at the same time:
  • Dilatrend (Unk)
  • Monoket (Unk)
  • Plavix (Unk)
  • Ascriptin (Unk)
  • Amiodar (Unk)
  • Mirapexin (Unk)
  • Enapren (Unk)
  • Minitran (Unk)
When commencing Torvast, the patient experienced the following unwanted symptoms /side effects:
  • Hypercreatinaemia
  • Blood Creatine Phosphokinase Increased
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as hypercreatinaemia, may become evident only after a product is in use by the general population.

Gamma-glutamyltransferase Increased
This is a Torvast side effect report of a 86-year-old female patient (weight: NA) from IT. The patient developed the following symptoms/conditions: hypercholesterolaemia and was treated with Torvast (dosage: 40 Mg, 1x/day) starting Mar 05, 2012. Concurrently used drugs:
  • Dilatrend
  • Duoplavin
  • Eutirox
Soon after that, the consumer experienced the following of symptoms:
  • Gamma-glutamyltransferase Increased
The patient was hospitalized. This opens a possibility that Torvast could cause gamma-glutamyltransferase increased and that some female patients may be more susceptible.

Intentional Overdose, Intentional Self-injury, Electrocardiogram Qt Prolonged, Hypotension, Syncope
A 41-year-old female patient (weight: NA) from IT with the following symptoms: intentional overdose started Torvast treatment (dosage: 35 Df, Unit Doses Total) on Feb 25, 2013. Soon after starting Torvast treatment, the consumer experienced several side effects, including:
  • Intentional Overdose
  • Intentional Self-injury
  • Electrocardiogram Qt Prolonged
  • Hypotension
  • Syncope
. Concurrently used drugs:
  • Depakin Chrono (40 Df, Unit Doses Total)
  • Cipralex (70 Df, Unit Doses Total)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Torvast side effects, such as intentional overdose.

Hypokalaemia, Myalgia, Rhabdomyolysis, Hypomagnesaemia, Blood Parathyroid Hormone Decreased
This hypokalaemia side effect was reported by a physician from IT. A 80-year-old male patient (weight:NA) experienced the following symptoms/conditions: dyslipidaemia,essential hypertension.The patient was prescribed Torvast (dosage: 40 Mg, Daily), which was started on 2008. Concurrently used drugs:
  • Norvasc (10 Mg, Unk)
  • Enapren (5 Mg, Unk)
  • Cardioaspirin (100 Mg, Unk)
  • Amaryl (2 Mg, Unk)
  • Avodart (0.5 Mg, Unk)
  • Xatral (10 Mg, Unk)
  • Omeprazolo Eg (20 Mg, Unk)
.When starting to take Torvast the consumer reported symptoms, such as:
  • Hypokalaemia
  • Myalgia
  • Rhabdomyolysis
  • Hypomagnesaemia
  • Blood Parathyroid Hormone Decreased
These side effects may potentially be related to Torvast. The patient was hospitalized.

Hepatotoxicity, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Alkaline Phosphatase Increased
This is a report of a 80-year-old female patient (weight: NA) from IT, suffering from the following symptoms/conditions: hypercholesterolaemia, who was treated with Torvast (dosage: 40 Mg, Daily, start time: Nov 01, 2012), combined with:
  • Ticlopidine (Unk)
  • Zarelis (Unk)
  • Folina (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Hepatotoxicity
  • Gamma-glutamyltransferase Increased
  • Transaminases Increased
  • Blood Alkaline Phosphatase Increased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Torvast treatment in female patients, resulting in hepatotoxicity side effect.

Myositis
This report suggests a potential Torvast Myositis side effect(s) that can have serious consequences. A 41-year-old male patient (weight: NA) from IT was diagnosed with the following symptoms/conditions: hypercholesterolaemia and used Torvast (dosage: 20 Mg, Daily) starting Jan 01, 2008. Soon after starting Torvast the patient began experiencing various side effects, including:
  • Myositis
Drugs used concurrently: NA.The patient was hospitalized. Although Torvast demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as myositis, may still occur.

Eczema, Erythema, Impetigo, Pain, Pruritus
This Eczema, Erythema, Impetigo, Pain, Pruritus problem was reported by a physician from IT. A 85-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Nov 04, 2012 this consumer started treatment with Torvast (dosage: Unk). The following drugs were being taken at the same time:
  • Cumadin (Unk)
  • Zyloric (300 Ug, Daily)
  • Clexane (Unk)
  • Cardioaspirin (Unk)
  • Rocefin (Unk)
When commencing Torvast, the patient experienced the following unwanted symptoms/side effects:
  • Eczema
  • Erythema
  • Impetigo
  • Pain
  • Pruritus
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as eczema, may become evident only after a product is in use by the general population.

Gamma-glutamyltransferase Increased, Jaundice, Hypertransaminasaemia
This is a report of a 81-year-old female patient (weight: NA) from IT. The patient developed the following symptoms/conditions: hyperlipidaemia and was treated with Torvast (dosage: 20 Mg, 1x/day) starting Nov 20, 2010. Concurrently used drugs:
  • Eutirox (50 Ug, Unk)
  • Cardicor (1.25 Mg, Unk)
  • Pritor (80 Mg, Unk)
  • Lanoxin (0.125 Mg, Unk)
Soon after that, the consumer experienced the following side effects:
  • Gamma-glutamyltransferase Increased
  • Jaundice
  • Hypertransaminasaemia
The patient was hospitalized. This opens a possibility that Torvast treatment could cause the above reactions, including gamma-glutamyltransferase increased, and some female subjects may be more susceptible.

Hepatitis Acute
A 78-year-old female patient (weight: NA) from IT with the following symptoms/conditions: hypercholesterolemia started Torvast treatment (dosage: 40 Mg, Daily) on Jan 01, 2009. Soon after starting Torvast treatment, the subject experienced various side effects, including:
  • Hepatitis Acute
Concurrently used drugs:
  • Metoprolol
  • Combisartan
  • Noradox
  • Zyloric
This finding indicates that some female patients could be more vulnerable to Torvast.

1 of 4 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Torvast Side Effects

    Did You Have a Torvast Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Torvast for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Torvast Safety Alerts, Active Ingredients, Usage Information

    NDC0179-0141
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameATORVASTATIN CALCIUM
    NameATORVASTATIN CALCIUM
    Dosage FormTABLET, FILM COATED
    RouteORAL
    On market since20131105
    LabelerKAISER FOUNDATION HOSPITALS
    Active Ingredient(s)ATORVASTATIN CALCIUM
    Strength(s)80
    Unit(s)mg/1
    Pharma ClassHMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

    More About Torvast

    Side Effects reported to FDA: 80

    Torvast safety alerts: 2012 2010 2003

    Reported deaths: 4

    Reported hospitalizations: 47

    Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance

    [Posted 11/28/2012]

    AUDIENCE: Pharmacy, Patient, Health Professional

    ISSUE: On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level. The Company is taking this voluntary action as a precautionary measure due to the fact that we cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand (less than 1 mm in size). Because of the size of the particles which may be present in the affected lots it is unlikely to cause a significant safety concern. However, the possibility of adverse experiences arising primarily due to physical irritation cannot be ruled out.

    BACKGROUND: The product is used to lower blood cholesterol and is packaged in plastic bottles, as 90 and 500 tablets per bottle. The affected lots of Atorvastatin Calcium Tablets and their respective NDC code, expiration date information can be found in the Firm Press Release. The recall does not affect or relate to the 80 mg dosage strength of Atorvastatin Calcium Tablets.

    RECOMMENDATION:  Consumers should immediately contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
       

    [11/29/2012 - Questions and Answers - FDA]

    [11/29/2012 - FDA Statement - FDA]

    [11/28/2012 - Firm Press Release - Ranbaxy Inc.]

    Latest Torvast clinical trials